Depreciation of Corbus Pharmaceuticals Holdings, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Corbus Pharmaceuticals Holdings, Inc. Depreciation for the quarter ending 31 Dec 2025 was $100,000.
  • Corbus Pharmaceuticals Holdings, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $200,000, a 67% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Depreciation for 2025 was $200,000, a 67% decline from 2024.
  • Corbus Pharmaceuticals Holdings, Inc. annual Depreciation for 2024 was $600,000, unchanged from 2023.
  • Corbus Pharmaceuticals Holdings, Inc. annual Depreciation for 2023 was $600,000, a 21% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Corbus Pharmaceuticals Holdings, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $200,000 $100,000 -$100,000 01 Oct 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $300,000 $100,000 -$100,000 -50% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $400,000 $100,000 -$100,000 -50% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $500,000 $100,000 -$100,000 -50% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $600,000 $0 -$18,130 -100% 01 Oct 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $618,130 $200,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $618,130 $200,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $618,130 $200,000 +$18,130 +10% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $600,000 $18,130 -$166,272 -90% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $766,272 $200,000 +$9,205 +4.8% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $757,067 $200,000 +$7,916 +4.1% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $749,151 $181,870 -$13,849 -7.1% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $763,000 $184,402 -$23,466 -11% 01 Oct 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $786,466 $190,795 -$65,491 -26% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $851,957 $192,084 -$71,576 -27% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $923,533 $195,719 -$76,467 -28% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $1,000,000 $207,868 -$74,377 -26% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $1,074,377 $256,286 +$54,207 +27% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $1,020,170 $263,660 -$56,528 -18% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $1,076,698 $272,186 -$47,302 -15% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $1,124,000 $282,245 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $202,079 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $320,188 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $319,488 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q2 2017 $114,682 $32,963 +$13,018 +65% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $101,664 $31,489 +$13,664 +77% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $88,000 $29,766 +$11,959 +67% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2017 2016 FY
Q3 2016 $76,041 $20,464 +$5,763 +39% 01 Jul 2016 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 $70,278 $19,945 +$13,824 +226% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $56,454 $17,825 +$12,454 +232% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $44,000 $17,807 01 Oct 2015 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q3 2015 $14,701 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $6,121 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016 2016 Q2
Q1 2015 $5,371 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1

Corbus Pharmaceuticals Holdings, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $200,000 -$400,000 -67% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $600,000 $0 0% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $600,000 -$163,000 -21% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $763,000 -$237,000 -24% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
2021 $1,000,000 -$124,000 -11% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
2020 $1,124,000 +$385,000 +52% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
2019 $739,000 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021 2020 FY
2016 $88,000 +$44,000 +100% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2017 2016 FY
2015 $44,000 +$33,595 +323% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2017 2016 FY
2014 $10,405 01 Jan 2014 31 Dec 2014 10-K 28 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.